Ultragenyx Pharmaceutical Inc 10-Q for FY2020 Q2
Ultragenyx Pharmaceutical Inc. (RARE)
10-Q
2020-07-30
For: 2020-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Ultragenyx Pharmaceutical Inc filed this 10-Q on July 30, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $61.71M
- up 155.5% from $24.15M a year earlier
- Net income
- $25.32M
- compared with a net loss of $99.17M a year earlier
- Diluted EPS
- $0.41
- compared with -$1.72 a year earlier